Transforming growth factor β superfamily signaling and its role in B-cell lymphoma.
Metadata
Show metadataAppears in the following Collection
- Institutt for klinisk medisin [10814]
Abstract
No abstract.List of papers
Paper I. Huse K, Bakkebø M, Oksvold MP, Wälchli S, Hilden VI, Forfang L, Bredahl ML, Liestøl K, Alizadeh AA, Smeland EB, Myklebust JH. Mechanistic basis for resistance to BMP-induced growth inhibition in B-cell lymphoma. Submitted, not yet published. The paper is removed from the thesis in DUO due to publisher restrictions. |
Paper II. Bakkebø M, Huse K, Hilden VI, Smeland EB, Oksvold MP. TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK. BMC Immunology 2010. 11: 57. The published version of this paper is available at: https://doi.org/10.1186/1471-2172-11-57 |
Paper III. Bakkebø M, Pedersen NM, Vietri M, Forfang L, Hilden VI, Liestøl K, Patzke S, Myklebust JH, Stenmark H, Smeland EB, Oksvold MP. SARA has a role in EGF receptor trafficking, but is not essential in TGF-β signaling. Submitted, not yet published. The paper is removed from the thesis in DUO due to publisher restrictions. |